18
Views
27
CrossRef citations to date
0
Altmetric
Original Article

Identification of Epitopes and Affinity Purification of Thyroid Stimulating Auto-Antibodies using Synthetic Human Tsh Receptor Peptides

, , , , &
Pages 287-299 | Received 09 Feb 1994, Published online: 07 Jul 2009

References

  • Burman KD, Baker JR. Immune mechanisms in Graves' disease. Endocrinol Rev 1985; 6: 183–232
  • Furmaniak J, Rees Smith B. The structure of thyroid auto-antigens. Autoimmunity 1990; 7: 66–80
  • Kasagi K, Hidaka A, Nakamura H, Takeuchi R, Misaki T, Iida Y. Thyrotropin receptor antibodies in hypothyroid Graves' disease. J Clin Endocrinol Metah 1993; 75: 504–508
  • Takasu N, Yamada T, Katakura M., Yemauchi K, Shimizu Y, Ishizuki Y. Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins. J Clin Endocrinol Metab 1987; 64: 239–245
  • Macchia E, Concetti R, Carone G, Borgoni F, Fenzi GF, Pinchera A. Demonstration of blocking immunoglobulins G, having a heterogeneous behaviour in sera of patients with Graves' disease: Possible coexistence of different autoantibodies directed to the TSH receptor. Clin Endocrinol (Oxf) 1988; 28: 147–156
  • Takasu N, Yamada T, Takasu M, Komiya I, Nagasawa Y, Asawa T. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N Engl J Med 1992; 326: 513–518
  • Tokuda Y, Kasagi K, Iida Y, Hatabu H, Misaki T, Arai K. Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells by crude immunoglobulin fractions from patients with goitrous and atrophic autoimmune thyroiditis. J Clin Endocrinol Metab 1988; 67: 251–258
  • Chiovato L, Vitti P, Santini F, Lopez G, Mammoli C, Bassi P. Incidence of antibodies blocking thyrotropin effect in vitro in patients with euthyroid or hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 1990; 71: 40–45
  • Chiovato L, Vitti P, Lombardi A, Lopez B, Santini F, Macchia E. Detection and characterization of autoantibodies blocking the TSH-dependent cAMP production using FRTL-5 cells. J Endocrinol Invest 1987; 10: 383–388
  • Libert F, Lefort A, Gerard C, Parmentier M, Perret J, Ludgate M. cloning, sequencing and expression of the human thyrotropin (TSH) receptor: Evidence for binding of autoantibodies. Biochem Biophys Res Commun 1989; 165: 1250–1255
  • Misrahi M, Loosfelt H, Atger M, Sar S, Guiochon-Mantcl A, Milgrom E. Clonining, sequencing and expression of human TSH receptor. Biochem Biophys Res Commun 1990; 166: 394–403
  • Nagayama Y, Kaufman KD, Seto P, Rapoport B. Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun 1989; 165: 1184–1190
  • Vassart G, Dumont JE. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocrinol Rev 1992; 13: 596–611
  • Akamizu T, Ikuyama S, Saji M, Kosugi S, Kozak C, Mc-Bride OW. Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: Expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies. Proc Natl Acad Sci, USA 1990; 87: 5677–5681
  • Sprengel R, Braun T, Nikolics K, Segaloff DL, Seeburg PH. The testicular receptor for follicle stimulating hormone: Structure and functional expression of cloned cDNA. Mol Endocrinol 1990; 4: 525–530
  • Frazier AL, Robbins LS, Stork PJ, Sprengel R, Segaloff DL, Cone RD. Isoloation of TSH and LH/CG receptor cDNAs from human thyroid: Regulation by tissue specific splicing. Mol Endocrinol 1990; 4: 1264–1276
  • Nagayama Y, Wadsworth HL, Chazcnbalk GD, Russo D, Seto P, Rapoport B. Thyrotropin-luteinizing hormone/ chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function. Proc Natl Acad Sci, usa 1991; 88: 902–905
  • Wadsworth HL, Chazenbalk GD, Nagayama Y, Russo D, Rapoport B. An insertion in the human thyrotropin receptor critical for high affinity hormone binding. Science 1990; 249: 1423–1425
  • Nagayama Y, Rapoport B. Role of the carboxyl-terminal half of the extracellular domain of the human thyrotropin receptor in signal transduction. Endocrinology 1992; 131: 548–552
  • Kosugi S, Ban T, Akamizu T, Kohn LD. Site-directed mutagenesis of a portion of the extracellular domain of the rat thyrotropin receptor important in autoimmune thryoid disease and nonhomologous with gonadotropin receptors. J BiolChem 1991; 266: 19413–19418
  • Kosugi S, Ban T, Kohn LD. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the tyrotropin receptor. Mol Endocrinol 1993; 7: 114–130
  • Endo T, Ohmori M, Ikeda M, Onaya T. Rabbit antibodies toward extracellular loops of the membrane spanning region of human thyrotropin receptor possess thyroid stimulating activities. Biochem Biophys Res Commun 1991; 181: 1035–1041
  • Kosugi S, Okajima F, Ban T, Hidaka A, Shenker A, Kohn LD. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. J Biol Chetn 1992; 267: 24153–24156
  • Kosugi S, Ban T, Akamizu T, Kohn LD. Role of cystein residues in the extracellular domain and exoplasmic loops of the transmembrane domain of the TSH receptor: Effect of mutation to serine on TSH receptor activity and response to thyroid stimulating autoantibodies. Biochem Biophys Res Commun 1992; 188: 1754–1762
  • Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993; 365: 649–651
  • Morris JC, Bergert ER, McCormick DJ. Structure-function studies of the human thyrotropin receptor: Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides. J Biol Chem 1993; 268: 10900–10905
  • Klee GG, Hay ID. Assessment of sensitive thyrotropin assays for an expanded role in thyroid function testing: Proposed criteria for analytic performance and clinical utility. J Clin Endocrinol Metab 1987; 64: 461–471
  • Morris JC, Hay ID, Nelson RE, Jiang N-S. Clinical utility of thyrotropin-receptor antibody assays: Comparison of radioreceptor and bioassay methods. Mayo Clin Proc 1988; 63: 707–717
  • Morris JC, Jiang N-S, Hay ID, Charlesworth MC, McCormick DJ, Ryan RJ. The effects of synthetic alpha-subunit peptides on thyroid-stimulating immunoglobulin activity. J Clin Endocrinol Metab 1988; 67: 707–712
  • Morris JC, Jiang N-S. Charlesworth MC, McCormick DJ, Ryan RJ. The effects of synthetic a-subunit peptides on thyrotropin interaction with its receptor. Endocrinology 1988; 123: 456–462
  • Wray HL, Glinos AD. Cyclic nucleotides and growth regulation in suspension culture of mammalian cells. Am J Physiol 1978; 234: CI31–138
  • Steiner AL, Parker CW, Kipnis DM. Radioimmunoassay of cyclic nucleotides. J Biol Chem 1972; 247: 1106–1113
  • Seetharamaiah GS, Kesai RK, Dallas JS, Tahara K, Kohn LD, Prabhakar BS. Induction of TSH binding inhibitory immunoglobulins with the extracellular domain of human thyrotropin receptor produced using baculovirus expression system. Autoimmunity 1993; 14: 315–320
  • Takai O, Desai RK, Seetharamaiah GS, Jones CA, Allaway GP, Akamizu T. Prokaryotic expression of the thyrotropin receptor and identification of an immunogenic region of the protein using synthetic peptides. Biochem Biophys Res Commun 1991; 179: 319–326
  • Desai RK, Dallas JS, Gupta MK, Seetharamaiah GS, Fan J-L, Tahara K. Dual mechanism of perturbation of thyrotropin-mediated activation of thyroid cells by antibodies to the thryotropin receptor (TSHR) and TSHR-derived peptides. J Clin Endocrinol Metab 1993; 77: 658–663
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
  • Endo T, Ohmori M, Ideda M, Onaya T. Thyroid stimulating activity of rabbit antibodies toward the human thyrotropin receptor peptide. Biochem Biophys Res Commun 1991; 177: 145–150
  • Murakami M, Mori M. Identification of immunogenic regions in human thyrotropin receptor for immunoglobulin G of patients with Graves' disease. Biochem Biophys Res Commun 1990; 171: 512–518
  • Ohmori M, Endo T, Ikeda M, Onaya T. Role of N-terminal region of the thyrotropin (TSH) receptor in signal transduction for TSH or thyroid stimulating antibody. Biochem Biophys Res Commun 1991; 178: 733–738
  • Ueda Y, Sugawa H, Akamizu T, Okuda J, Kiho Y, Mori T. Immunoglobulin G that interferes with thyroid-stimulating antibody measurements can be eliminated specifically by incubation with synthetic peptides corresponding to partial sequences of the human thyrotropin receptor. Thyroid 1993; 3: 111–117
  • Nagy EV, Burch HB, Mahoney K, Lukes YG, Morris JC, Burman KD. Graves' IgG recognizes linear epitopes in the human thyrotropin receptor. Biochem Biophys Res Commun 1992; 188: 28–33
  • Nagy EV, Burch HB, Lukes YG, Carr FE, Kosugi S, Kohn LD. Immunogenicity of a unique region of the human thyrotropin receptor. J Endocrinol Invest 1993; 16: 485–493
  • Piraphatdist T, Sugawa H, Inoue D, Enomoto T, Mori T, Imura H. Possible binding site of thyrotropin binding inhibitor immunoglobulin (TB1I) on the thyrotropin (TSH) receptor, which is different from TSH binding site. Biochem Biophys Res Commun 1990; 172: 529–536
  • Libert F, Ludgatc M, Dinsart G, Vassart G. Thyroperoxidase, but not the thyrotropin receptor, contains sequential epitopes recognized by autoantibodies in recombinant peptides expressed in the pUEX vector. J Clin Endocrinol Metab 1991; 73: 857–860
  • Kosugi S, Akamizu T, Takai O, Prabhakar BS, Kohn LD. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies. Thyroid 1991; 1: 321–330
  • Kosugi S, Ban T, Akamizu T, Kohn LD. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: These determinants have no homologous sequence on gonadotropin receptors. Mol Endocrinol 1992; 6: 168–180
  • Akamizu T, Inoue D, Kosugi S, Ban T, Kohn LD, Imura H. Chimeric studies of the extracellular domain of the rat thyrotropin (TSH) receptor: Amino acids (268-304) in the TSH receptor are involved in ligand high affinity binding, but are not in TSH receptor-specific signal transduction. Endocrine J 1993; 40: 363–372
  • Endo K, Amir SM, Ingbar SY. Development and evaluation of a method for the partial purification of immunoglobulins specific for Graves' disease. J Clin Endocrinol Metab 1981; 52: 1113–1123
  • Endo K, Borges M, Amir S, Ingbar SH. Preparation of 125I-labeled receptor-purified Graves' immunoglobulins: Properties of their binding to human thyroid membranes. J Clin Endocrinol Metab 1982; 5: 566–576
  • Nagayama Y, Wadsworth HL, Russo D, Chazenbalk GD, Rapoport B. Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors. J Clin Invest 1991; 88: 336–340
  • Wadsworth HL, Russo D, Nagayama Y, Chazenbalk GD, Rapoport B. Studies on the role of amino acids 38-45 in the expression of a functional thyrotropin receptor. Mol Endocrinol 1992; 6: 394–398
  • Davies DR, Padlan EA, Sheriff S. Antibody-antigen complexes. Ann Rev Biochem 1990; 59: 439–473

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.